Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma
Clinical trial NCT00072085 · COMPLETED
Trial details
- NCT number
- NCT00072085
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.